Eupraxia Pharmaceuticals (EPRX) Selling, General & Administrative (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 555.10 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.47 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 101.25 Mn |
| 10 | Eupraxia Pharmaceuticals | 357.29 Mn | 355.69 Mn | - | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 8.30 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 2.52 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 1.26 Mn |